My name is Kris L. Christine. I live in Maine and am the Founder and Co-Trustee of THE RABIES CHALLENGE FUND (www.RabiesChallengeFund.org). My precious canine companion, Meadow, developed a malignant mast cell tumor directly on the site of his rabies shot at the age of 6 (syringe hole still visible in the tumor) and died in July after repeated surgeries failed to yield clean margins and the cancer metasticized throughout his body.
It is my goal to make available to all dog owners the scientific data on the known durations of immunity for canine vaccines and the adverse reactions associated with them so that they can make informed vaccine decisions for their beloved companions. In 2004 I launched a successful effort to change Maine's rabies immunization regulations for dogs from 2 to 3 years and insert a medical exemption clause; later that year Representative Peter Rines introduced the nation's first pet vaccine disclosure legislation on my behalf.
If anyone would like copies of the American Animal Hospital Association's Canine Vaccine Guidelines, the 1992 French challenge study demonstrating that dogs were immune to a rabies challenge 5 years after vaccination, the 2003 Italian study documenting fibrosarcomas at the presumed injection sites of rabies vaccines in dogs, as well as Dr. W. Jean Dodds' papers on vaccinal adverse reactions, please e-mail me at firstname.lastname@example.org.
PERMISSION GRANTED TO CROSS-POST my vaccine informational posts.
Duration of Immunity to Canine Vaccines: What We Know and Don't Know, Dr. Ronald Schultz http://www.cedarbayvet.com/duration_of_immunity.htm
The 2003 American Animal Hospital Association's Canine Vaccine Guidelines are accessible online at http://www.leerburg.com/special_report.htm .
The 2006 American Animal Hospital Association's Canine Vaccine Guidelines are downloadable in PDF format at http://www.aahanet.org/PublicDocumen…s06Revised.pdf .
Veterinarian, Dr. Robert Rogers,has an excellent presentation on veterinary vaccines at http://www.newvaccinationprotocols.com/.